ASCARI, EDOARDO
 Distribuzione geografica
Continente #
NA - Nord America 3.795
AS - Asia 3.070
EU - Europa 2.803
SA - Sud America 325
AF - Africa 35
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 10.047
Nazione #
US - Stati Uniti d'America 3.725
CN - Cina 1.907
IE - Irlanda 686
SG - Singapore 599
UA - Ucraina 468
FI - Finlandia 365
DE - Germania 338
HK - Hong Kong 304
RU - Federazione Russa 284
BR - Brasile 271
SE - Svezia 270
GB - Regno Unito 135
IT - Italia 109
VN - Vietnam 102
FR - Francia 52
CA - Canada 48
IN - India 41
AR - Argentina 24
NL - Olanda 19
BE - Belgio 17
IR - Iran 17
BD - Bangladesh 16
JP - Giappone 16
PL - Polonia 15
ZA - Sudafrica 14
MX - Messico 13
AU - Australia 11
ES - Italia 10
ID - Indonesia 9
EC - Ecuador 8
AT - Austria 7
SA - Arabia Saudita 7
VE - Venezuela 7
DK - Danimarca 6
PK - Pakistan 6
UZ - Uzbekistan 6
CO - Colombia 5
IQ - Iraq 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
EU - Europa 4
JO - Giordania 4
MA - Marocco 4
NP - Nepal 4
RO - Romania 4
EG - Egitto 3
GE - Georgia 3
GR - Grecia 3
IL - Israele 3
LT - Lituania 3
TR - Turchia 3
AZ - Azerbaigian 2
BB - Barbados 2
BY - Bielorussia 2
CL - Cile 2
JM - Giamaica 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
LK - Sri Lanka 2
ML - Mali 2
MU - Mauritius 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
UY - Uruguay 1
Totale 10.047
Città #
Dublin 684
Chandler 591
Jacksonville 570
Nanjing 455
Hong Kong 299
Beijing 287
Dallas 284
Ashburn 266
Singapore 244
Boardman 202
Nanchang 191
Princeton 137
Shenyang 126
Hebei 125
Lawrence 125
Medford 121
Changsha 114
Wilmington 112
Jiaxing 99
Los Angeles 92
Helsinki 91
Ann Arbor 77
Tianjin 74
Hangzhou 72
Munich 70
Moscow 57
New York 50
Buffalo 48
Shanghai 44
Milan 43
Redondo Beach 43
Turku 37
Ho Chi Minh City 35
Woodbridge 33
Norwalk 28
Hanoi 24
São Paulo 24
Verona 24
Seattle 20
Fairfield 19
Toronto 19
Montreal 18
Brussels 17
Chicago 17
Guangzhou 15
Houston 15
Tokyo 15
Warsaw 14
Kunming 13
Denver 11
Jinan 11
San Francisco 11
Brooklyn 10
Santa Clara 10
The Dalles 10
Zhengzhou 10
Auburn Hills 9
Brasília 9
Chennai 9
Des Moines 9
Falkenstein 9
Boston 8
Johannesburg 8
Ningbo 8
Piscataway 8
San Genesio Ed Uniti 8
Taizhou 8
Belo Horizonte 7
London 7
Phoenix 7
Poplar 7
Atlanta 6
Changchun 6
Columbus 6
Falls Church 6
Haiphong 6
Manchester 6
Orange 6
Orem 6
Andover 5
Ardabil 5
Fuzhou 5
Lanzhou 5
Melbourne 5
Quito 5
Rio de Janeiro 5
Rome 5
Tashkent 5
Amman 4
Amsterdam 4
Campinas 4
Mexico City 4
Shijiazhuang 4
Sorocaba 4
Barueri 3
Biên Hòa 3
Bắc Ninh 3
Cleveland 3
Colombo 3
Fes 3
Totale 6.509
Nome #
5' Nucleotidase in chronic B cell leukemias: a cytochemical and ultrastructural study 130
A modified high-dose dexamethasone regimen for primary systemic amyloidosis 125
A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes 123
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. 118
[Biochemical modifications of the erythrocyte membrane in various red cell disorders] 115
[Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons] 113
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 112
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 112
Anomalous erythrocytes produced by rabbits with liver damage. 111
Ageing of rabbit red cells in vitro: membrane modifications and their possible role in red cell survival in vivo. 111
AMYLOIDOSIS AL 108
Acute promyelocitic leukemia toluidine blue subtype. 108
Acute phase proteins and prognosis in multiple myeloma. 106
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 105
A prospective, controlled, non-randomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple myeloma. 104
Severe platelet disfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIa 104
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol 102
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 101
A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12) 101
- Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in an hematological/oncological outpatient section 99
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. 97
[Glycoproteins of the erythrocyte membrane in normal and pathological conditions] 97
Advanced breast cancer: a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil. 96
Acquired immune thrombastenia: a new bleeding disorder. 96
Silymarine during maintenance therapy of acute promyelocytic leukemia. 96
Anemie megaloblastiche. 96
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. 95
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function. 94
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 93
Reactive hemophagocytosis in Ki-1 positive largeb cell lymphoma: a case study. 93
Response to cyclosporin A and rhG-CSF in a case of aplastic anemia. 93
The clinical value of tumor burden at diagnosis in Hodgkin lymphoma 92
On the usefulness of PAS reaction for the prognosis of acute lymphoblastic leukemia. 92
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 91
Analysis of Vlambda-Jlambda expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambda III) as a new amyloid-associated germline gene segment 91
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 90
Possible evolution of human parvovirus B19 infection into erythroleukemia 90
[Prophylaxis and therapy of neuro-meningeal involvement of acute lymphoblastic leukemia. Case reports and critical review of literature (author's transl)] 89
[Pure acute monocytic leukaemia: morphological, cytochemical and clinical study of 14 cases (author's transl)]. 89
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 87
Presentation features of monoclonal gammopathies: analysis of 684 newly diagnosed cases. 85
Biologia e clinica del mieloma multiplo. 85
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis 83
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma. 83
Changing clinical presentation of multiple myeloma. 82
Significance of marrow-blood barrier for CFU-GM in patients with acute nonlymphoid leukemia (AnLL) 82
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy: cytokinetic effects on bone marrow hematopoietic progenitors. 81
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 81
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 81
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 81
Sequential vincristine, arabinosylcytosine and daunomycin in acute leukemia: a preliminary report. 81
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 81
RELEVANCE OF CLASS, MOLECULAR WEIGHT AND ISOELECTRIC POINT IN PREDICTING HUMAN LIGHT CHAIN AMYLOIDOGENICITY. 80
Membrane CD22 defines circulating myeloma-related cells as mature or later B cells 80
Applicazioni cliniche dei fattori di crescita emopoietici. 79
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 79
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 79
Clinical relevance of two in vitro tests based on CFU-GM assay in the study of granulopoietic failure 79
Fisiopatologia dell'eritrocito. 78
Cancer chemotherapy-related thrombotic thrombocytopeic purpura: biological evidence of increased nitric oxide production. 78
Expression of p53, bcl-2 and ras oncoproteins in acute leukemias and myelodysplastic syndromes 78
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 78
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy. An echocardiographic study. 77
Effects of desferrrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies 77
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 77
Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati [Avascular jaw osteonecrosis associated with bisphophonate therapy]. 77
Acute non-lymphoblastic leukemia. Correlation between clinical and hematological parameters in 87 adult patients. 77
[Chronic granulomatous disease with sea-blue histiocytosis: a case report (author's transl)]. 77
Glycopeptides of erythrocyte membranes in some hematological disorders 76
Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP 76
Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura 76
International prognostic scoring system and other prognostic systems for myelodysplastic syndromes. 75
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis 75
The syndrome of abnormal chromatin clumping in leucocytes: clinical and biological study of a case. 75
Chemotherapy-induced leukonychia 75
Evidence of a hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli L-asparaginase: a GIMEMA study. 74
Applicazioni cliniche della citometria. 73
Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. The Italian Cooperative Group for TTP 72
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes anf granulocyte colony-stimulating factor in breast cancer patients 71
Acute promyelocytic leukemia: morphological and clinical features. 71
Lymphocyte reactivity in chronic lymphocytic leukaemia: effect of repeated and prolonged stimulation with PHA and PWM. 70
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry 69
Structural modifications in membrane glycoproteins during the erythrocyte life-span. 69
In vivo behaviour of neuraminidase-treated rabbit erythrocytes and reticulocytes 69
Behaviour of young and old desialylated rabbit erythrocytes in vivo. 69
IL MIELOMA MULTIPLO 69
Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high risk myelodysplastic syndromes 69
Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony stimulating factor. 68
Terapia del mieloma multiplo. 68
Flow cytometric analysis of multidrug resistance antigen (p glicoprotein) and DNA ploidy in human colon cancer 67
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. 67
Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP 67
Tetrahydrofolate dehydrogenase cytochemistry in acute lymphoblastic leukemia. 66
Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers. 66
Membrane sialic acid and behaviour in vivo of rabbit "stress" macroreticulocytes. 66
Erythrocyte membrane modifications in chronic granulocytic leukaemia 65
Flow cytometric analysis of paraffin embedded material in human gastric cancer. 65
Immunocytochemical detection of factor XIII A--subunit in acute leukemia. 64
Loss of the Y chromosome in smoldering acute leukemia. 64
Thalidomide treatment reduces apoptosis levels in bone marrow cells from patients with myelodysplastic syndromes 64
Totale 8.531
Categoria #
all - tutte 42.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.917


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021589 0 0 0 0 0 129 3 134 32 137 117 37
2021/2022650 9 1 21 10 24 35 12 35 23 32 88 360
2022/20231.811 217 129 21 136 183 174 0 85 777 9 54 26
2023/2024550 80 92 25 59 51 133 15 32 7 14 25 17
2024/20251.566 44 142 37 52 25 49 53 109 391 47 183 434
2025/20261.954 275 254 441 523 421 40 0 0 0 0 0 0
Totale 10.121